A Global Multi-Center Prospective Observational Cohort to Support Drug Development in Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC)
Status: Recruiting
Location: See all (11) locations...
Study Type: Observational
SUMMARY
Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:
• Adult patients between 18 and 75 years of age (inclusive) who can comprehend instructions, follow the study procedures and are willing to sign an Informed Consent Form (ICF).
• Confirmed clinical diagnosis of large duct PSC.
Locations
United States
California
UC Davis
RECRUITING
Sacramento
California Pacific Medical Center
RECRUITING
San Francisco
University of California, San Francisco
RECRUITING
San Francisco
Connecticut
Yale University
RECRUITING
New Haven
Florida
Schiff Center for Liver Diseases / University of Miami
RECRUITING
Miami
Indiana
Indiana University
RECRUITING
Indianapolis
Massachusetts
Massachusetts General Hospital
RECRUITING
Boston
Virginia
Virginia Commonwealth University
RECRUITING
Richmond
Other Locations
Canada
University of Alberta
RECRUITING
Edmonton
University Health Network
RECRUITING
Toronto
Germany
University Medical Center Hamburg-Eppendorf
RECRUITING
Hamburg
Contact Information
Primary
Stephen Rossi, PharmD
stephen@pscpartners.org
3037715227
Backup
Priya Kannusamy
priya@pscpartners.org
3037715227
Time Frame
Start Date: 2024-05-06
Estimated Completion Date: 2031-01
Participants
Target number of participants: 2000
Treatments
Adult patients with a confirmed diagnosis of large duct PSC.
1. Adult patients between 18 and 75 years of age (inclusive) who can comprehend instructions, follow the study procedures and are willing to sign an Informed Consent Form (ICF).~2. Confirmed clinical diagnosis of large duct PSC
Related Therapeutic Areas
Sponsors
Leads: PSC Partners Seeking a Cure